Pages that link to "Q41292997"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications (Q41292997):
Displaying 50 items.
- Pumped up: reflections on PfATP6 as the target for artemisinins (Q22061938) (← links)
- Quinine for muscle cramps (Q24186617) (← links)
- Quinine for muscle cramps (Q24235626) (← links)
- Quinine for muscle cramps (Q24247271) (← links)
- Artemisinin combination therapy for vivax malaria (Q24622539) (← links)
- Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan (Q24801453) (← links)
- Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines (Q24815604) (← links)
- Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda (Q24815752) (← links)
- Pharmacokinetic drug interactions in liver disease: An update (Q26774479) (← links)
- Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity (Q28066142) (← links)
- Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers (Q28469106) (← links)
- The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria (Q28478579) (← links)
- Chloroquine is grossly under dosed in young children with malaria: implications for drug resistance (Q28539103) (← links)
- Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates (Q28542863) (← links)
- Effect of Phospholipidosis on the Cellular Pharmacokinetics of Chloroquine (Q30498935) (← links)
- Autophagy in oncogenic K-Ras promotes basal extrusion of epithelial cells by degrading S1P (Q30572504) (← links)
- Diversity and severity of adverse reactions to quinine: A systematic review (Q33429589) (← links)
- Pharmacokinetic properties of azithromycin in pregnancy (Q33558917) (← links)
- A case of acute interstitial nephritis and granulomatous hepatitis induced by ingesting quinine (Q33628263) (← links)
- Should people with nocturnal leg cramps drink tonic water and bitter lemon? (Q33639370) (← links)
- Essential amino acid ingestion alters expression of genes associated with amino acid sensing, transport, and mTORC1 regulation in human skeletal muscle. (Q33660488) (← links)
- Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy (Q33676120) (← links)
- An integrated model of chloroquine action (Q33719332) (← links)
- Recent developments in the management of malaria (Q33910813) (← links)
- Population pharmacokinetics of intramuscular quinine in children with severe malaria (Q33982327) (← links)
- New concepts in antimalarial use and mode of action in dermatology (Q34007922) (← links)
- Slow clearance of Plasmodium vivax with chloroquine amongst children younger than six months of age in the Brazilian Amazon. (Q34142715) (← links)
- Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria (Q34252476) (← links)
- Pharmacokinetic interactions of antimalarial agents (Q34296740) (← links)
- Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing (Q34299078) (← links)
- Altered temporal response of malaria parasites determines differential sensitivity to artemisinin (Q34329125) (← links)
- Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda (Q34331026) (← links)
- Human alpha-1-glycoprotein and its interactions with drugs (Q34331335) (← links)
- Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review (Q34646141) (← links)
- Plasmodium falciparum resistance to cytocidal versus cytostatic effects of chloroquine (Q35004539) (← links)
- Model system to define pharmacokinetic requirements for antimalarial drug efficacy (Q35007051) (← links)
- Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure. (Q35065737) (← links)
- Efficacy of sulphadoxine-pyrimethamine artesunate, sulphadoxine-pyrimethamine amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali (Q35078892) (← links)
- Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model (Q35139464) (← links)
- Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy (Q35205935) (← links)
- Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo (Q35220039) (← links)
- Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa (Q35602042) (← links)
- Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs. (Q35607534) (← links)
- Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria (Q35825980) (← links)
- Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar (Q35834329) (← links)
- Antimalarial combinations (Q35840382) (← links)
- Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections (Q36018719) (← links)
- Validation of a chloroquine-induced cell death mechanism for clinical use against malaria (Q36179646) (← links)
- Cytoadherence and severe malaria. (Q36202059) (← links)
- Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection (Q36320042) (← links)